Palakurthi, Sangeetha <br/><br/>
The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity.  [electronic resource] 

 -  Cancer immunology research  Sep 2019 
 - 1457-1471 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2326-6074 
<br/><br/><label>Standard No.: </label>10.1158/2326-6066.CIR-18-0595  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Immunological--pharmacology<br/>Biomarkers<br/>Cell Line, Tumor<br/>Disease Models, Animal<br/>Drug Synergism<br/>Humans<br/>Immunity--drug effects<br/>Immunophenotyping<br/>Lymphocytes, Tumor-Infiltrating--drug effects<br/>Mice<br/>Mice, Transgenic<br/>Mutation<br/>Neoplasms--drug therapy<br/>Prognosis<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Pyrazoles--pharmacology<br/>Quinoxalines--pharmacology<br/>Receptors, Antigen, T-Cell--genetics<br/>Receptors, Fibroblast Growth Factor--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>T-Lymphocyte Subsets--drug effects<br/>Treatment Outcome<br/>Tumor Microenvironment